However, the studies conducted so far indicated that significant changes in the levels of apelin/ELABELA have been observed in the placenta, maternal serum, and the foetus during IUGR pregnancy [157,158,159,160,161,162,163]. The gene discussed is APLN; the disease is fetal growth restriction.